NCT07382557 Adaptation and Pilot Testing of a Lung Cancer Screening Decision Aid for Patients From a Safety-Net Healthcare System
| NCT ID | NCT07382557 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Lung Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 360 participants |
| Start Date | 2022-09-29 |
| Primary Completion | 2027-02-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 360 participants in total. It began in 2022-09-29 with a primary completion date of 2027-02-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the study is to adapt and test a participant decision aid about lung cancer screening for use with patients in theHarris Health System (HHS).
Eligibility Criteria
Inclusion Criteria: 1. 50-80 years of age 2. Current smokers or smokers who have quit less than 15 years ago 3. Speak either English or Spanish 4. No history of lung cancer 5. Family member of someone with a history of smoking AND lung cancer Exclusion Criteria:
Contact & Investigator
Robert Vok, PHD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT07382557 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 80 Years, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07382557 currently recruiting?
Yes, NCT07382557 is actively recruiting participants. Contact the research team at bvolk@mdanderson.org for enrollment information.
Where is the NCT07382557 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT07382557 clinical trial?
NCT07382557 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Robert Vok, PHD at M.D. Anderson Cancer Center. The trial plans to enroll 360 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.